As a shareholder I am pleased to observe that the company appears to have advanced
considerably since the last AGM, in line with the strategy explained at the time by the
then newly appointed CEO, Pascal Soriot (PS). The market perceived the company as
having severe problems due to a “cliff” of patent expiries, impacting future revenues and
profits. Astra’s pipeline of new products, to replace revenues & profits from products
with expiring patents, was perceived as weak.
As disclosed in the annual report and in the ...